Intuitive Surgical heads into the final stretch of October nursing a 4.5% weekly loss, even as the analyst community emerged from Q3 results mostly constructive on the robotic surgery franchise. The Street's reaction to the October 20 print was broadly positive in direction but mixed in conviction. JPMorgan's Robbie Marcus raised his target to $475 from $450, keeping Overweight…
ISRG cost to borrow surges 134% in one week to 0.32%, up from a low of 0.14% on October 5, though remains historically subdued amid light short interest of 2.1% of free float.
Key data as of 9 Nov 2026
ISRG cost to borrow surges 134% in one week to 0.32%, up from a low of 0.14% on October 5, though remains historically subdued amid light short interest of 2.1% of free float.
Intuitive Surgical arrives at its October 20 earnings report having recovered sharply from the July lows, with short sellers pulling back and the lending market so loose it barely registers as a headwind. The clearest…
Intuitive Surgical heads into its October 20 earnings report with a fresh Barclays initiation pulling in the same direction as the broader Street consensus, even as the stock trades 15% below the average analyst target…
Intuitive Surgical presents an unusual setup this week: short sellers are cutting positions at pace while the stock trades 8% below its one-month high, leaving the stock cheaper than it has been all summer with the…
Intuitive Surgical reports Q2 results on July 16 with the Street broadly bullish but meaningfully more cautious on valuation than it was three months ago. The most telling pre-earnings signal is the wave of…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ISRG — free to start on ORTEX.
Sign up for free →Open ISRG on ORTEX